CIK 0001175680
- Non-accelerated filer
- Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753056237
- Phone
- +1 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- 5 Insider Annual Insider Trading Report
- 4 Shares withheld for taxes President & CEO gave up 156,570 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 4,078,774 shares (option exercise)
- 4/A Open-market sale Chairman & CMO sold 1,200,000 shares at $3.26 ($3,912,480)
- 4 Open-market sale Chief Medical Officer sold 1,200,000 shares at $3.26 ($3,912,480)
- 4 Open-market sale President & CEO sold 4,821,174 shares at an average $3.27 ($15,760,910)
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 7 of 22 · 435 filings